191 related articles for article (PubMed ID: 15051639)
1. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Steinberg JS; Sadaniantz A; Kron J; Krahn A; Denny DM; Daubert J; Campbell WB; Havranek E; Murray K; Olshansky B; O'Neill G; Sami M; Schmidt S; Storm R; Zabalgoitia M; Miller J; Chandler M; Nasco EM; Greene HL
Circulation; 2004 Apr; 109(16):1973-80. PubMed ID: 15051639
[TBL] [Abstract][Full Text] [Related]
2. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
[TBL] [Abstract][Full Text] [Related]
5. Rate control versus rhythm control.
Vidaillet H; Greenlee RT
Curr Opin Cardiol; 2005 Jan; 20(1):15-20. PubMed ID: 15596954
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L
Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis.
Choudhry NK; Zagorski B; Avorn J; Levin R; Sykora K; Laupacis A; Mamdani M
Ann Pharmacother; 2008 Nov; 42(11):1563-72. PubMed ID: 18827174
[TBL] [Abstract][Full Text] [Related]
10. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.
Am J Cardiol; 1997 May; 79(9):1198-202. PubMed ID: 9164885
[TBL] [Abstract][Full Text] [Related]
12. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
Blackshear JL; Safford RE; ;
Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
[TBL] [Abstract][Full Text] [Related]
13. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
Kaufman ES; Zimmermann PA; Wang T; Dennish GW; Barrell PD; Chandler ML; Greene HL;
J Am Coll Cardiol; 2004 Sep; 44(6):1276-82. PubMed ID: 15364332
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
15. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
[TBL] [Abstract][Full Text] [Related]
16. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
Freudenberger RS; Wilson AC; Kostis JB;
Am J Cardiol; 2007 Jul; 100(2):247-52. PubMed ID: 17631079
[TBL] [Abstract][Full Text] [Related]
18. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
Van Gelder IC; Wyse DG; Chandler ML; Cooper HA; Olshansky B; Hagens VE; Crijns HJ;
Europace; 2006 Nov; 8(11):935-42. PubMed ID: 16973686
[TBL] [Abstract][Full Text] [Related]
19. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
Cooper HA; Bloomfield DA; Bush DE; Katcher MS; Rawlins M; Sacco JD; Chandler M;
Am J Cardiol; 2004 May; 93(10):1247-53. PubMed ID: 15135698
[TBL] [Abstract][Full Text] [Related]
20. Impact of lipid-lowering therapy on outcomes in atrial fibrillation.
Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
Am J Cardiol; 2010 Jun; 105(12):1768-72. PubMed ID: 20538128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
